Cellular and humoral markers of systemic inflammation in acute reactive arthritis and early rheumatoid arthritis

Scandinavian Journal of Rheumatology

Volumn 33, Issue 1, 2004, Pages 13-18

  Kuuliala, A ^a,c   Takala, A ^b   Siitonen, S ^b   Leirisalo Repo, M ^b   Repo, H ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CD11B ANTIGEN; CELL MARKER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; PROCALCITONIN;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD CULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MEASUREMENT; MONOCYTE; NEUTROPHIL; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REACTIVE ARTHRITIS; RHEUMATOID ARTHRITIS; SEPSIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD11; ARTHRITIS, REACTIVE; ARTHRITIS, RHEUMATOID; BACTEREMIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; E-SELECTIN; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 1542297647     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009740310004135     Document Type: Article

References (44)

1. Ebringer A, Rashid T, Wilson C. Rheumatoid arthritis: proposal for the use of anti-microbial therapy in early cases. Scand J Rheumatol 2003;32:2-11.
2. Toivanen P. Normal intestinal microbiota in the aethiopathogenesis of rheumatoid arthritis. Ann Rheum Dis 2003;62:807-11.
3. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-34.
4. Newman W, Beall LD, Carson CW, Hunder GG, Graben N, Randhawa ZI, et al. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 1993;150:644-54.
5. Takala A, Nupponen I, Kylänpää-Bäck ML, Repo H. Markers of inflammation in sepsis. Ann Med 2002;34:614-23.
6. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-8.
7. Meisner M. Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 2002;323:17-29.
8. Calin A. Reiter's syndrome. In: Calin A, editor. Spondylarthropathies. Orlando: Grune and Stratton; 1984. p. 119-50.
9. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
10. Repo H, Jansson SE, Leirisalo-Repo M. Flow cytometric determination of CD11b upregulation in vivo. J Immunol Methods 1993;164:193-202.
11. Felzmann T, Gadd S, Majdic O, Maurer D, Petera P, Smolen J, et al. Analysis of function-associated receptor molecules on peripheral blood and synovial fluid granulocytes from patients with rheumatoid and reactive arthritis. J Clin Immunol 1991;11:205-12.
12. McCarthy DA, Bernhagen J, Taylor MJ, Hamblin AS, James I, Thompson PW, et al. Morphological evidence that activated polymorphs circulate in the peripheral blood of patients with rheumatoid arthritis. Ann Rheum Dis 1992;51:13-8.
13. Crockard AD, Thompson JM, McBride SJ, Edgar JD, McNeill TA, Bell AL. Markers of inflammatory activation: upregulation of complement receptors CR1 and CR3 on synovial fluid neutrophils from patients with inflammatory joint disease. Clin Immunol Immunopathol 1992;65:135-42.
14. McCarthy D, Taylor MJ, Bernhagen J, Perry JD, Hamblin AS. Leucocyte integrin and CR1 expression on peripheral blood leucocytes of patients with rheumatoid arthritis. Ann Rheum Dis 1992;51:307-12.
15. Watson F, Robinson JJ, Phelan M, Bucknall RC, Edwards SW. Receptor expression in synovial fluid neutrophils from patients with rheumatoid arthritis. Ann Rheum Dis 1993;52:354-9.
16. De Clerck LS, De Gendt CM, Bridts CH, Van Osselaer N, Stevens WJ. Expression of neutrophil activation markers and neutrophil adhesion to chondrocytes in rheumatoid arthritis patients: relationship with disease activity. Res Immunol 1995;146:81-7.
17. Lopez S, Halbwachs-Mecarelli L, Ravaud P, Bessou G, Dougados M, Porteu, et al. Neutrophil expression of tumour necrosis factor receptors (TNF-R) and of activation markers (CD11b, CD43, CD63) in rheumatoid arthritis. Clin Exp Immunol 1995;101:25-32.
18. Storgaard M, Jensen MP, Stengaard-Pedersen K, Moller BK, Anderson PL, Obel N. Effects of methotrexate, sulphasalazine and aurothiomalate on polymorphonuclear leucocytes in rheumatoid arthritis. Scand J Rheum 1996;25:168-73.
19. Nielsen H, Petersen AA, Skjodt H, Horslev-Petersen K, Bendtzen K. Blood levels of CD11b+ memory T lymphocytes are selectively upregulated in patients with active rheumatoid arthritis. APMIS 1999;107:1124-30.
20. Macey MG, Wilton JM, Carbon R, Edmonds S, Perry JD, McCarthy D. Leukocyte activation and function-associated antigens in inflammatory disease. Agents Actions 1993;38:C39-C40.
21. Torsteinsdottir I, Arvidson NG, Hallgren R, Hakansson L. Enhanced expression of integrins and CD66b on peripheral blood neutrophils and eosinophils in patients with rheumatoid arthritis, and the effect of glucocorticoids. Scand J Immunol 1999;50:433-9.
22. Jones J, Laffafian I, Cooper AM, Williams BD, Morgan BP. Expression of complement regulatory molecules and other surface markers on neutrophils from synovial fluid and blood of patients with rheumatoid arthritis. Br J Rheum 1994;33:707-12.
23. Crocker IP, Baker PN, Fletcher J. Neutrophil function in pregnancy and rheumatoid arthritis. Ann Rheum Dis 2000;59:555-64.
24. Higaki M, Miyasaka N, Sato K. Increased expression of CD11b (Mo1) on peripheral blood monocytes of patients with rheumatoid arthritis. J Rheumatol 1992;19:825-6.
25. Highton J, Carlisle B, Palmer DG. Changes in the phenotype of monocytes/macrophages and expression of cytokine mRNA in peripheral blood and synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 1995;102:541-6.
26. Liote F, Boval-Boizard B, Weill D, Kuntz D, Wautier JL. Blood monocyte activation in rheumatoid arthritis: increased monocyte adhesiveness, integrin expression, and cytokine release. Clin Exp Immunol 1996;106:13-9.
27. Torsteinsdottir I, Arvidson NG, Hallgren R, Hakansson L. Monocyte activation in rheumatoid arthritis (RA): increased integrin, Fc gamma and complement receptor expression and the effect of glucocorticoids. Clin Exp Immunol 1999; 115:554-60.
28. Repo H, Jansson SE, Leirisalo-Repo M. Flow cytometric determination of CD11b upregulation in vivo. J Immunol Methods 1993;164:193-202.
29. McCarthy DA, Macey MG, Cahill MR, Newland AC. Effect of fixation on quantification of the expression of leucocyte function-associated surface antigens. Cytometry 1994;17:39-49.
30. Kirveskari J, He Q, Holmstrom T, Leirisalo-Repo M, Wuorela M, Mertsola J, et al. Modulation of peripheral blood mononuclear cell activation status during Salmonella-triggered reactive arthritis. Arthritis Rheum 1999;42:2045-54.
31. El Habbal MH, Smith L, Elliott MJ, Strobel S. Effect of heparin anticoagulation on neutrophil adhesion molecules and release of IL8: C3 is not essential. Cardiovasc Res 1995;30:676-81.
32. Takala A, Jousela I, Olkkola KT, Jansson SE, Leirisalo-Repo M, Takkunen O, Repo H. Systemic inflammatory response syndrome without systemic inflammation in acutely ill patients admitted to hospital in a medical emergency. Clin Sci (London) 1999;96:287-95.
33. Kylanpaa-Back ML, Takala A, Kemppainen E, Puolakkainen P, Kautiainen H, Jansson SE, et al. Cellular markers of systemic inflammation and immune suppression in patients with organ failure due to severe acute pancreatitis. Scand J Gastroenterol. 2001;36:1100-7.
34. Kylanpaa-Back ML, Takala A, Kemppainen EA, Puolakkainen PA, Leppaniemi AK, Karonen SL, et al. Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis. Crit Care Med 2001;29:63-9.
35. Pesonen EJ, Hockerstedt K, Makisalo H, Vuorte J, Jansson SE, Orpana A, et al. Transhepatic neutrophil and monocyte activation during clinical liver transplantation. Transplantation 2000;69:1458-64.
36. Takala AJ, Jousela IT, Takkunen OS, Jansson SE, Kyosola KT, Olkkola KT, et al. Time course of beta 2-integrin CD11b/CD18 (Mac-1, alpha M beta 2) upregulation on neutrophils and monocytes after coronary artery bypass grafting. CD11b upregulation after CABG surgery. Scand J Thorac Cardiovasc Surg. 1996;30:141-8.
37. Vuorte J, Lindsberg PJ, Kaste M, Meri S, Jansson SE, Rothlein R, Repo H. Anti-ICAM-1 monoclonal antibody R6.5 (Enlimomab) promotes activation of neutrophils in whole blood. J Immunol 1999;162:2353-7.
38. Schwenger V, Sis J, Breitbart A, Andrassy K. CRP levels in autoimmune disease can be specified by measurement of procalcitonin. Infection 1998;26:274-6.
39. Cohen J. The immunopathogenesis of sepsis. Nature 2002;420:885-91.
40. Granfors K, Merilahti-Palo R, Luukkainen R, Mottonen T, Lahesmaa R, Probst P, et al. Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis. Arthritis Rheum 1998;41:855-62.
41. Repo H, Renkonen R, Helander IM, Leirisalo-Repo M. Alkali-treated LPS of Yersinia enterocolitica does not induce expression of E-selectin, ICAM-1 or VCAM-1 on endothelial cells but may mediate antibody- and complement-dependent cell injury. Scand J Immunol 1994;39:241-8.
42. Oberhoffer M, Stonans I, Russwurm S, Stonane E, Vogelsang H, Junker U, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 1999;134:49-55.
43. Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 1993;119:1198-208.
44. Kuuliala A, Eberhardt K, Takala A, Kautiainen H, Repo H, Leirisalo-Repo M. Circulating soluble E-selectin in early rheumatoid arthritis: a prospective five year study. Ann Rheum Dis 2002;61:242-6.